ARCT

#3091
Arcturus Therapeutics Holdings Inc. - Common Stock
7.9 3 USD
+0.13%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
7.87
7.96
년간 변동
5.86
24.14
일일 변동
+0.13%
월간 변동
-5.26%
6달 변화
+17.83%
년간 변동율
-37.21%
이전 종가
7.9 2
Open
7.9 0
저가
7.8 7
High
7.9 6
양
169
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
손익계산서 대차대조표 현금 흐름
값 Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Arcturus Therapeutics Holdings Inc. - Common Stock

Arcturus Therapeutics Holdings Inc. is an American RNA medicines biotechnology company focused on the discovery, development and commercialization of therapeutics for rare diseases and infectious diseases. Arcturus has developed proprietary lipid nanoparticle RNA therapeutics for nucleic acid medicines including small interfering RNA, messenger RNA, gene editing RNA, DNA, antisense oligonucleotides, and microRNA. The company develops RNA therapeutics for the treatment of rare diseases such as ornithine transcarbamylase deficiency, and respiratory diseases such as cystic fibrosis. Vaccine medicines include a vaccine candidate for COVID-19 and an influenza vaccine in the preclinical development phase. The vaccine for COVID-19 was authorised in Japan in 2023 and the European Union in 2025.

뉴스